Dublin, July 01, 2022 (GLOBE NEWSWIRE) -- The "Endoscopy Market Analysis by Product, by Application (Laparoscopy, Gastrointestinal, Obstetrics, Urology, Arthroscopy), by End-Use, and by Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global endoscopy market size is estimated to be USD 33.76 billion in 2021 and is expected to witness a CAGR of 6.85% during the forecast period.
Rising old-age population coupled with rising demand for minimally invasive surgery are key drivers for the growth of the global endoscopy market. Additionally, the increasing R&D in medical devices, changing lifestyle owing to rise in disposable income, government support, and growing cases of chronic diseases are some of the other drivers propelling the market growth. However, the expensive endoscopic procedure and difficult medical reimbursement policies are expected to restrain the global market growth
By Product
Based on product, the market is segmented into robot-assisted, disposable, capsule, rigid, and flexible. In 2021, the flexible endoscopes segment accounted for the largest revenue share with lucrative CAGR during the forecast period. This is attributed to the enhanced efficiency and safety, coupled with technological advancements in the medical-optics field. Disposable endoscopy segment projected to grow at the fastest CAGR during the forecast period. This is attributed to the rising need for one-time use of scopes, thereby minimizing the danger of infections associated with medical devices.
By Application
Based on application, the market is categorized into laparoscopy, gastrointestinal (GI) endoscopy, obstetrics/gynaecology endoscopy, urology endoscopy (cystoscopy), arthroscopy, bronchoscopy, otoscopy, mediastinoscopy, laryngoscopy, and others. The gastrointestinal (GI) endoscopy segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period.
The rise in incidences of gastroscopies, increase in adoption of endoscopic procedures for diagnosis and treatment, coupled with the accessibility of advanced gastroscopy devices is a key factor that drives the segment growth. The urology endoscopy segment is anticipated to grow at the fastest CAGR during the forecast period, due to the rising cases of haematuria, bladder cancer, & urinary tract stones, increasing incidences of urinary disorders, coupled with a growing old-age population.
By End-Use
Based on end-use, the market is categorized into ambulatory surgery centres, hospitals, and others. The hospitals segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. The high preference for the endoscopic procedure in hospitals at large-scale is a key factor that drives the segment growth. The ambulatory surgery centres segment is anticipated to grow at the fastest CAGR during the forecast period owing to the shorter treatment wait time experienced by patients at these centres.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the high awareness for endoscopy, presence of leading medical device companies, advanced healthcare infrastructure, and high investments in R&D in this region.
Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the rising incidences of chronic diseases, escalating demand for advanced medication and treatment, and growing focus of government in this region.
Competitor Insights
Some of the key players in the endoscopy market are Medtronic plc (Ireland); Richard Wolf GmbH (Germany); CONMED (U.S.); Hoya Corporation (Japan); Stryker Corporation (U.S.); Karl Storz SE & Co. KG (Germany); Boston Scientific Corporation (U.S.); Fujifilm Holdings (Japan); Johnson & Johnson (U.S.) and Olympus Corporation (Japan).
The leading players operating in the endoscopy industry are adopting various strategies including R&D investments, novel product launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029.
Key Topics Covered:
1. Research Methodology
2. Introduction: Endoscopy
3. Executive Summary
3.1. Global Market Scenario
3.2. Segment Market Scenario
3.3. Geographic Market Scenario
3.4. COVID-19 Impact
3.5. Competitive Landscape
4. Market Dynamics
4.1. Market Drivers
4.1.1. Driver 1
4.1.2. Driver 2
4.1.3. Driver 3
4.1.4. Driver 4
4.1.5. Driver 5
4.2. Market Restraint
4.2.1. Restraint 1
4.2.2. Restraint 2
4.2.3. Restraint 3
4.2.4. Restraint 4
4.3. Market Opportunities
4.3.1. Opportunity 1
4.3.2. Opportunity 2
4.3.3. Opportunity 3
4.3.4. Opportunity 4
4.4. Market Trends
4.4.1. Trend 1
4.4.2. Trend 2
4.4.3. Trend 3
4.4.4. Trend 4
4.5. Market Challenges
4.5.1. Challenge 1
4.5.2. Challenge 2
4.5.3. Challenge 3
4.5.4. Challenge 4
5. Market Environment Analysis
5.1. Porter's 5 Forces Analysis
5.2. PESTEL Analysis
5.3. Value Chain Analysis
5.4. SWOT Analysis
5.5. Benchmark
6. COVID-19 Impact Analysis: Endoscopy Market
6.1. COVID-19: Overview
6.2. COVID-19 Impact on the Global Market
6.3. COVID-19 Impact on the Regional Markets
7. Market Analysis by Product
7.1. Robot Assisted Endoscopes
7.1.1. Robot Assisted Endoscopes Market Forecast, 2021-2029 (USD Million)
7.2. Disposable Endoscopes
7.2.1. Disposable Endoscopes Market Forecast, 2021-2029 (USD Million)
7.3. Capsule Endoscopes
7.3.1. Capsule Endoscopes Market Forecast, 2021-2029 (USD Million)
7.4. Rigid Endoscopes
7.4.1. Rigid Endoscopes Market Forecast, 2021-2029 (USD Million)
7.5. Flexible Endoscopes
7.5.1. Flexible Endoscopes Market Forecast, 2021-2029 (USD Million)
8. Market Analysis by Application
8.1. Laparoscopy
8.1.1. Laparoscopy Market Forecast, 2021-2029 (USD Million)
8.2. Gastrointestinal (GI) endoscopy
8.2.1. Gastrointestinal (GI) endoscopy Market Forecast, 2021-2029 (USD Million)
8.3. Obstetrics/gynecology endoscopy
8.3.1. Obstetrics/gynecology endoscopy Market Forecast, 2021-2029 (USD Million)
8.4. Urology endoscopy (cystoscopy)
8.4.1. Urology endoscopy (cystoscopy) Market Forecast, 2021-2029 (USD Million)
8.5. Arthroscopy
8.5.1. Arthroscopy Market Forecast, 2021-2029 (USD Million)
8.6. Bronchoscopy
8.6.1. Bronchoscopy Market Forecast, 2021-2029 (USD Million)
8.7. Otoscopy
8.7.1. Otoscopy Market Forecast, 2021-2029 (USD Million)
8.8. Mediastinoscopy
8.8.1. Mediastinoscopy Market Forecast, 2021-2029 (USD Million)
8.9. Laryngoscopy
8.9.1. Laryngoscopy Market Forecast, 2021-2029 (USD Million)
8.10. Others
8.10.1. Others Market Forecast, 2021-2029 (USD Million)
9. Market Analysis by End User
9.1. Ambulatory Surgical Centres
9.1.1. Ambulatory Surgical Centres Market Forecast, 2021-2029 (USD Million)
9.2. Hospitals
9.2.1. Hospitals Market Forecast, 2021-2029 (USD Million)
9.3. Others
9.3.1. Others Market Forecast, 2021-2029 (USD Million)
10. Regional Market Analysis
10.1. Regional Market Trends
10.2. Regional Market: Comparative Analysis
11. North America Endoscopy Market
12. Europe Endoscopy Market
13. Asia Pacific Endoscopy Market
14. Latin America Endoscopy Market
15. MEA Endoscopy Market
16. Competitor Analysis
16.1. Market Share Analysis, 2021 & 2029
16.2. Competitive Mapping
16.3. Key Players Market Place Analysis
16.4. Major Recent Developments
17. Company Profiles
17.1. Medtronic plc (Ireland)
17.1.1. Company Snapshot
17.1.2. Company Overview
17.1.3. Financials
17.1.4. Application Benchmarking
17.1.5. Recent Developments
17.2. Richard Wolf GmbH (Germany)
17.2.1. Company Snapshot
17.2.2. Company Overview
17.2.3. Financials
17.2.4. Application Benchmarking
17.2.5. Recent Developments
17.3. CONMED (U. S.)
17.3.1. Company Snapshot
17.3.2. Company Overview
17.3.3. Financials
17.3.4. Application Benchmarking
17.3.5. Recent Developments
17.4. Hoya Corporation (Japan)
17.4.1. Company Snapshot
17.4.2. Company Overview
17.4.3. Financials
17.4.4. Application Benchmarking
17.4.5. Recent Developments
17.5. Stryker Corporation (U. S.)
17.5.1. Company Snapshot
17.5.2. Company Overview
17.5.3. Financials
17.5.4. Application Benchmarking
17.5.5. Recent Developments
17.6. Karl Storz SE & Co. KG (Germany)
17.6.1. Company Snapshot
17.6.2. Company Overview
17.6.3. Financials
17.6.4. Application Benchmarking
17.6.5. Recent Developments
17.7. Boston Scientific Corporation (U. S.)
17.7.1. Company Snapshot
17.7.2. Company Overview
17.7.3. Financials
17.7.4. Application Benchmarking
17.7.5. Recent Developments
17.8. Fujifilm Holdings (Japan)
17.8.1. Company Snapshot
17.8.2. Company Overview
17.8.3. Financials
17.8.4. Application Benchmarking
17.8.5. Recent Developments
17.9. Johnson & Johnson (U. S.)
17.9.1. Company Snapshot
17.9.2. Company Overview
17.9.3. Financials
17.9.4. Application Benchmarking
17.9.5. Recent Developments
17.10. Olympus Corporation (Japan)
17.10.1. Company Snapshot
17.10.2. Company Overview
17.10.3. Financials
17.10.4. Application Benchmarking
17.10.5. Recent Developments
17.11. Holografika Kft. (Hungary)
17.11.1. Company Snapshot
17.11.2. Company Overview
17.11.3. Financials
17.11.4. Product Benchmarking
17.11.5. Recent Developments
17.12. Company 12
17.12.1. Company Snapshot
17.12.2. Company Overview
17.12.3. Financials
17.12.4. Product Benchmarking
17.12.5. Recent Developments
17.13. Company 13
17.13.1. Company Snapshot
17.13.2. Company Overview
17.13.3. Financials
17.13.4. Product Benchmarking
17.13.5. Recent Developments
17.14. Company 14
17.14.1. Company Snapshot
17.14.2. Company Overview
17.14.3. Financials
17.14.4. Product Benchmarking
17.14.5. Recent Developments
17.15. Company 15
17.15.1. Company Snapshot
17.15.2. Company Overview
17.15.3. Financials
17.15.4. Product Benchmarking
17.15.5. Recent Developments
17.16. Others Prominent Players
18. Conclusion & Recommendations
For more information about this report visit https://www.researchandmarkets.com/r/ed1guj
